
Apogee Therapeutics, Inc.
USD134.20
+0.05 (+0.04%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$134.16
Prev. Close
$134.15
Day Low
$134.11
Day High
$134.35
52W Low
$34.34
52W High
$134.35
Market Cap
$8.30B
Volume
0.42M
| TD Cowen |
| Buy |
| Hold |
| downgrade |
| 23 Jun 2026 | RBC Capital | Sector Perform | Sector Perform | maintain |
| 23 Jun 2026 | Citigroup | Buy | Neutral | downgrade |
| 23 Jun 2026 | UBS | Buy | Neutral | downgrade |
| 23 Jun 2026 | Deutsche Bank | Buy | Hold | downgrade |
| 23 Jun 2026 | Wedbush | Outperform | Neutral | downgrade |
| 22 Jun 2026 | Canaccord Genuity | Buy | Hold | downgrade |